Delivery Order SPE2DB20D3103-SPE2DB25FQ4V6
Award Date 9/26/25
Potential Completion Date 9/29/25
Potential Value $14K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 15, 2025, for Thrombin-JMI 20,000 unit vials valued at $6,276.96. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a competitive award with no set-aside designation. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract under AmerisourceBergen's...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, the Corporate Office Division of Amerisourcebergen Corporation, a major pharmaceutical distribution company. The contract, valued at $4,180.74, is for the delivery of 5,000 unit vials of the drug Thrombin-JMI, a topical hemostatic agent used to control bleeding. The contract is a firm fixed price, full and open competition award with no set-aside designation....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $5,895.82 on August 26, 2025, for the supply of Thrombin-JMI 5,000 units vials, with an ultimate completion date of August 27, 2025. This firm fixed price contract is non-competitive and non-set-aside, with performance to be executed at the company's corporate office location in Conshohocken, Pennsylvania. The award is funded through the Defense Logistics Agency's Medical Supply Chain, a defense-focused federal agency responsible...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on August 28, 2025, for Thrombin-JMI 5,000 unit epistaxis products valued at $1,639.81. This is a firm fixed-price delivery order with an ultimate completion date of August 29, 2025, and represents a non-set-aside competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, serves as a critical federal medical...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications, with a firm fixed price ceiling value of $6,998.20. The award, executed on August 19, 2025, with an ultimate completion date of August 20, 2025, represents a competitively awarded, non-set-aside contract. The contract will be fulfilled from AmerisourceBergen's operations in...
- This federal contract award is for the delivery of 5,000-unit vials of Thrombin-JMI, a pharmaceutical product, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract, valued at $10,872.51, was awarded to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, on August 30, 2024. The contract is a Delivery Order with a Firm Fixed Price pricing type and has an ultimate completion date of September 3, 2024. This award is not associated with a set-aside program. As...
- The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical distribution company. The contract is for the supply of 5,000 unit vials of Thrombin-JMI, a specialty pharmaceutical product, with a potential value of $1,615.50. The contract has a completion date of March 6, 2024 and was awarded on March 5, 2024. No set-aside designation was...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order for 20,000 unit vials of Recothrom (thrombin topical), a hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $7,567.75, was awarded on July 21, 2025, with an ultimate completion date of July 22, 2025. The contract was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for 20,000 unit vials of Recothrom, a thrombin-based hemostatic agent used in surgical applications. This firm fixed-price delivery order, valued at $25,119.14, was competitively awarded without set-aside designation and is scheduled for completion by September 9, 2025. The product will be delivered to AmerisourceBergen's distribution facility in Conshohocken, Pennsylvania, where the company maintains its...
- AmerisourceBergen Drug Corp was awarded a delivery order on July 23, 2025, by the Defense Logistics Agency Medical Supply Chain to supply 20,000 unit vials of RECOTHROM (thrombin topical) with a ceiling value of $9,422.34. This non-competitive, firm fixed-price delivery order is part of AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order is set to be completed by July 24,...